Published: 07/15/2026 | Author: Terri

Authorities out in New Mexico weigh whether to pursue civil damages against the federal government because of a decision from the DEA to let known fentanyl shipments enter the state between 2023 and 2025. 

The number of opioid-related deaths has fallen nationwide, but each death takes a toll. The Land of Enchantment offers programs like inpatient care and community Narcotics Anonymous chapters. But these services run the risk of becoming overwhelmed as more narcotics pour into the city streets.

The Controversy Over Fentanyl

DEA agents monitored but didn’t intercept fentanyl so that they could build up cases against trafficking networks. A DEA whistleblower relayed that this strategy risked public safety due to fentanyl’s dangerous effects and countered Justice Department rules meant to protect communities. The inaction coincides with Justice Department guidance revisions in 2024 to give agents discretion over when to seize fentanyl. This move contradicts earlier orders to seize shipments whenever “practicable.”

The DEA has since asked the Justice Department’s independent inspector general to investigate the allegations. New Mexico’s attorney general separately opened a state criminal investigation into whether federal officials may have broken state law by knowingly allowing fentanyl to reach New Mexico communities.

New Mexico’s Response

Governor Michelle Lujan Grisham relayed that the state could seek billions of dollars in civil damages over the DEA’s handling of the fentanyl shipments. She called the situation “a stunning failure by the federal government.” Grisham pointed to New Mexico’s 21% increase in overdose deaths even as overdose deaths fell nationally by 14% over the same period. The governor also cited the death of a 15-month-old child who reportedly ingested a parent’s drugs in Española.

Albuquerque Mayor Tim Keller also weighed in. He called fentanyl the city’s “No. 1 challenge” and described its effect on crime, homelessness and strain on local health care resources.

The Federal Response

A White House spokesperson asserted that President Trump has classified fentanyl a “weapon of mass destruction” and signed legislation targeting synthetic opioid trafficking while attributing ongoing fentanyl harms in part to previous administrations. The Justice Department offered a similar statement. The DEA hasn’t issued a detailed public response beyond calling for the inspector general’s review.

It remains unclear whether any specific overdose deaths in New Mexico are directly linked to the unseized shipments described in the reporting. Both sides continue to dispute how much responsibility rests with which administration or agency.

An Overview of Fentanyl and Harm Reduction

The controversy reflects the deadly nature of the opioid crisis. Fentanyl is a synthetic opioid much more powerful than most street drugs. Even small amounts can be fatal especially when mixed into other drugs without a person’s knowledge. 

Naloxone, sold under brand names including Narcan, can reverse an opioid overdose if administered quickly and is available without a prescription in most states. Fentanyl test strips can also help people identify fentanyl in a substance before use. 

Medication-assisted treatment with buprenorphine or methadone and inpatient or outpatient rehab programs are all part of the response available to people affected by opioid addiction in New Mexico and nationally.

No method fully substitutes for calling emergency services during a suspected overdose.

NA Can Help Those Impacted

Regardless of how the investigation unfolds, public health officials on both sides of the debate agree that expanding access to treatment remains critical. 

Those who aren’t sure how to take the first step towards recovery can take heart. Narcotics Anonymous offers a free and friendly way to build a network of fellowship. Meet your peers in a local setting, share stories and resources and even offer a shoulder to cry on—or do just that.

NA chapters exist all across the country. Simply browse our directory to find one in any location. Or call 800-934-1582(Sponsored) for confidential guidance on treatment options.